文献速递皮肤肿瘤

2001至2020年英格兰原位黑色素瘤与恶性黑色素瘤的发病率和死亡率

Incidence and mortality of melanoma in situ and malignant melanoma in England between 2001 and 2020.
PubMed 文献 · Br J Dermatol · 2025-01-01

该研究分析英格兰2001至2020年国家疾病登记数据,纳入86 792例原位黑色素瘤(MIS)和220 286例恶性黑色素瘤(MM)。MM年龄标准化发病率增长放缓,MIS亦趋稳;MM死亡率在75岁以下下降,但75岁以上男性仍上升。

要点

  • MM年龄标准化发病率增长从2001-6年APC 6.3%降至2014-19年APC 1.4%。
  • 0-24岁人群MM和MIS的年龄别发病率自2000年代末以来下降。
  • 75岁以上男性MM发病率和死亡率增长最快,需加强早期检测。

核心结论

  • MM和MIS发病率增长减速可能反映诊断漂移稳定、族裔多样性和减少日晒行为。
  • MM死亡率自2010年代初治疗进展后下降,但75岁以上男性仍上升。

研究设计与样本

  • 基于英格兰国家疾病登记服务2001-2020年常规收集数据的回顾性分析。
  • 纳入MIS 86 792例和MM 220 286例,使用joinpoint回归计算年龄标准化和年龄别发病率与死亡率趋势。

主要发现

  • MM的EASIR从2001年14.6/10万人年升至2019年28.7/10万人年,增长速率逐渐放缓。
  • MIS的EASIR从2001年4.5/10万人年升至2019年13.3/10万人年,2015年后增长减缓。
  • 0-24岁人群MM和MIS的ASIR自2000年代末下降;>50岁MM的ASIR上升,>70岁增幅最大。
  • 自2010年代初起MM的EASMR男性持续高于女性;<74岁成人ASMR下降,>75岁继续上升。

临床怎么用

  • 关注75岁以上男性高风险人群,推进早期黑色素瘤检测。
  • 继续开展公众防晒意识宣传和改善黑色素瘤诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An increase in the incidence of melanoma has been reported globally since the late twentieth century, while mortality from melanoma is no longer increasing in England and other countries. Improved therapeutics have reduced mortality. However, this phenomenon implicates 'overdiagnosis', where thinner melanomas of unclear malignant potential are being diagnosed possibly due to 'diagnostic drift'. OBJECTIVES: To assess the age-standardized and age-specific incidence and mortality trends for melanoma in situ (MIS) and malignant melanoma (MM) in England between 2001 and 2020 by age and gender. METHODS: We analysed routinely collected data from the National Disease Registration Service for MIS and MM in England between 2001 and 2020. We used joinpoint regression analysis to calculate the trends and average annual percentage change (APC) in age-standardized (using the 2013 European Standard Population) incidence (EASIR) and mortality (EASMR) and age-specific incidence (ASIR) and mortality (ASMR) rates, by age and gender per 100 000 person years (PYs). RESULTS: Between 2001 and 2020, 86 792 cases of MIS and 220 286 cases of MM were recorded in England. The EASIR (per 100 000 PYs) for MM increased most rapidly during 2001-6 (from 14.6 to 19.6; APC 6.3%); the rate of increase slowed during 2006-14 (APC 4.1%; EASIR2014 26.7) and decelerated further between 2014 and 2019 (APC 1.4%; EASIR2019 28.7). The EASIR for MIS (per 100 000 PYs) increased rapidly during 2001-15 (from 4.5 to 12.5; APC 7.5%) and subsequently slowed between 2015 and 2019 (to EASIR2019 13.3; APC 1.9%). In individuals 0-24 years old, the ASIR of MM and MIS has been decreasing since the late 2000s, whereas the ASIR of MM in those aged > 50 years is rising, with the greatest increases seen in those aged > 70 years. Since the early 2010s, EASMRs from MM have remained higher in men. ASMRs have reduced in adults < 74 years of age; however, rates have continued to increase in those > 75 years old. CONCLUSIONS: The deceleration in the incidence rates of MM and MIS may be due to stabilization of any diagnostic drift, ethnicity diversity and reduced sun-seeking behaviours, particularly in younger generations. Mortality rates from MM have decreased since therapeutic developments in the early 2010s, and in younger generations before this. MM incidence and mortality are increasing most rapidly in men aged > 75 years, the age group with the highest incidence and expected growth in the future. These results support the importance of early melanoma detection, public health sun-awareness campaigns and better melanoma diagnostics. Melanoma is a type of skin cancer that became more common in the 20th century. Recent data from England show that a smaller proportion of people younger than 75 years old are dying from melanoma compared with the past. We examined how new melanoma diagnoses and melanoma deaths have changed in England, during 2001–20, in people of different ages. We did this by analysing electronic national registry data. We found that melanoma rates have slowed down and are reducing for younger people (0–24 years old). We also found that the number of deaths from melanoma have been decreasing in people under 60 years of age and started decreasing in the early 2010s for people 60–74 years old. However, they are still increasing in people over 75 years of age. Our findings support the idea that increased awareness of melanoma and changing criteria for diagnosing the disease may have led to an increase in rates in the past. Melanoma rates have recently stabilized in England, possibly due to better sun behaviours and the effects of prevention campaigns. A decrease in deaths from melanoma may be the result of earlier diagnosis resulting in better outcomes, changes in how and when melanoma is diagnosed, and the availability of new treatments.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Karponis D, van Bodegraven B, Mistry K, et al. Incidence and mortality of melanoma in situ and malignant melanoma in England between 2001 and 2020. Br J Dermatol. 2025. PMID: 40228809. doi:10.1093/bjd/ljaf136

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。